Penserra Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9
| Closed | – | – | 1112 |
|
|
2024
Q3 | $0 | Sell |
9
-3
| -25% | – | ﹤0.01% | 1120 |
|
|
2024
Q2 | $1K | Sell |
12
-3
| -20% | -$250 | ﹤0.01% | 1208 |
|
|
2024
Q1 | $1K | Hold |
15
| – | – | ﹤0.01% | 1165 |
|
|
2023
Q4 | $1K | Hold |
15
| – | – | ﹤0.01% | 1214 |
|
|
2023
Q3 | $1K | Buy |
15
+5
| +50% | +$333 | ﹤0.01% | 1212 |
|
|
2023
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 1264 |
|
|
2023
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 1125 |
|
|
2022
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 1077 |
|
|
2020
Q2 | – | Sell |
-1,115
| Closed | -$106K | – | 810 |
|
|
2020
Q1 | $106K | Buy |
+1,115
| New | +$106K | 0.01% | 553 |
|
|
2019
Q3 | – | Sell |
-1,596
| Closed | -$136K | – | 859 |
|
|
2019
Q2 | $136K | Buy |
+1,596
| New | +$136K | 0.01% | 443 |
|
|
2017
Q1 | – | Sell |
-224
| Closed | -$18K | – | 588 |
|
|
2016
Q4 | $18K | Buy |
224
+39
| +21% | +$3.13K | ﹤0.01% | 680 |
|
|
2016
Q3 | $17K | Buy |
185
+74
| +67% | +$6.8K | ﹤0.01% | 602 |
|
|
2016
Q2 | $9K | Buy |
111
+41
| +59% | +$3.32K | ﹤0.01% | 719 |
|
|
2016
Q1 | $5 | Buy |
70
+2
| +3% | – | ﹤0.01% | 828 |
|
|
2015
Q4 | $7K | Buy |
+68
| New | +$7K | ﹤0.01% | 602 |
|